Modulus Discovery, Inc., an early stage drug discovery company announced today the signing of a multi-target research collaboration with Professor Osamu Nureki of Department of Biological Sciences, Graduate School of Science, University of Tokyo for structural analysis on several drug target proteins.

Professor Nureki is a renowned structural biologist recently awarded the Purple Ribbon* from Japan’s Emperor in May 2018 for his significant lifetime scientific contributions in the field. He is known globally for his prolific structure determination of multiple membrane proteins including GPCRs and ion channels. Recently, he has been expanding his interests into cryo-electron microscopy (CryoEM) analysis of molecules for structures that have been difficult to be determined by traditional methods such as x-ray crystallography.

The collaboration provides Modulus privileged access to novel structures of high value targets that have strong synergies to Modulus’ proprietary computational platform.

Comment from S. Roy Kimura, CEO of Modulus Discovery, Inc.:

“We are very excited to initiate our collaboration with the University of Tokyo’s Professor Nureki, a top authority in the field of protein structure analysis both in x-ray crystallography and CryoEM. Our early access to novel drug target structures generated by Professor Nureki’s laboratory will help accelerate delivery of innovative drug candidates.”

Comment from Professor Osamu Nureki, University of Tokyo:

“I’m thrilled to start this collaboration that may potentially deliver multiple drugs in future. With our expertise in protein structural analysis and Modulus’ state-of-the-art simulation and computational compound design platform, I expect rapid delivery of novel treatment options to address current high unmet medical needs” said Professor Osamu Nureki.